• nba买球推荐蔗糖
  • 竞彩篮球nba
  • 公司优势/
  • 完善质量管理体系
  • 自主核心技术发明专利
  • 全球化营销网络
  • 强大团队
  • 新闻中心/
  • 企业新闻
  • 行业新闻
  • 会展信息/
  • 人才招聘/
  • 招聘职位
  • 联系我们/
  • 公司地图
  • nba买球推荐蔗糖业务
  • 竞彩篮球nba业务
  • ChemChina-Syngenta $43 billion deal approved by U.S. Security Panel
    时间:2016-09-12 点击:3573

    voltaren

    voltaren click here

    am i fat or pregnant quiz

    am i pregnant teenage quiz read

    buy naltrexone online cheap

    naltrexone buy uk link

    prednisolone

    prednisolon

    amlodipin actavis

    amlodipin teva bivirkninger

    imipramin kopfschmerzen

    imipramin strukturformel http://ndkobkobenhavn.site/hvad-er-imipramin.html imipramin side effects

    A U.S. national security panel has cleared ChemChina's $43 billion takeover of Swiss pesticides and seeds group Syngenta, the companies said, boosting chances that the largest foreign acquisition ever by a Chinese company will go through.

    The decision removes significant uncertainty over the takeover of the world's largest pesticides maker after the two companies agreed a deal in February.

    Syngenta did not disclose whether it had made concessions to secure approval but indicated that any such steps would not have a significant impact on its business.

    Syngenta shares jumped 11.2 percent by 0900 GMT to 423.4 Swiss francs ($439.7). ChemChina's $465 per share cash offer values the company at around 448 francs at current exchange rates plus a special five-franc dividend.

    Kepler Cheuvreux analyst Christian Faitz called the step a "major milestone for the deal", adding in a note to clients that "approval removes a major potential hurdle and should come as a relief to Syngenta shareholders". Kepler Cheuvreux rates Syngenta shares a "Buy".

    Reuters reported earlier on Monday that the acquisition was in the final stages of being cleared by a U.S. panel that scrutinises deals for national security implications.

    "China National Chemical Corporation (ChemChina) and Syngenta today announced that the companies have received clearance on their proposed transaction from the Committee on Foreign Investment in the United States (CFIUS)," a joint statement released by Syngenta said.

    The statement made no mention of any concessions required to win clearance.

    "We are not disclosing the details of the agreement with CFIUS to respect the confidentiality of the process," a Syngenta spokesman said by email in response to a Reuters query. "Any mitigation measures are not material to Syngenta's business."

    Syngenta reiterated that is expected the deal to be finalised by the end of the year.

    It said closing the transaction was subject to "anti-trust review by numerous regulators around the world and other customary closing conditions. Both companies are working closely with the regulatory agencies involved and discussions remain constructive."